The COVID-19 pandemic forced units and offices throughout the Defense Department to stock up on a range of supplies, from disposable masks to gloves and disinfectant, all of which could be purchased with a government-issued credit card and paid off by the Pentagon.

But a DOD Inspector General review of more than 100,000 government purchase card transactions made from March 2020 to January 2022 reveals that roughly $54 million in purchases didn’t align with COVID-19 necessities.

That is nearly 40% of the $242 million spent on such needs, according to the IG report.

Another $52 million, in purchases wasn’t properly documented, and the IG was unable to verify what the cardholders actually bought.

“The audit determined that DOD [government purchase card] program officials did not conduct the required oversight to identify and correct improper or unsupported purchases by cardholders for the DOD’s response to COVID-19,” Robert Storch, the Pentagon’s inspector general, said in a Jan. 17 release accompanying the report.

The White House’s declaration of a national emergency freed up millions of dollars to be spent on pandemic response, but the IG’s report concluded that a large chunk of what DOD spent during that time was paid for with emergency funds despite the purchases having nothing to do with the pandemic.

In one example, an Army cardholder spent $2,000 on a plumber to investigate a sinkhole, then coded the purchase as “COVID-19.” The official who then signed off on the expense didn’t correct the coding.

In another, an Air Force cardholder spent $540 on internet service. When questioned, the command blamed “oversight error and high turnover rate at the location,” according to the report.

The erroneously coded transactions weren’t corrected, according to the report, because the officials charged with reviewing transactions didn’t do their jobs, despite existing guidelines requiring such reviews within 60 days.

“Addressing these issues is crucial to maintaining accountability, transparency, and the effective use of taxpayer resources in the response to COVID-19 and any future pandemics,” Storch said in the release.

When asked about their review practices, the Army said there was confusion about the requirements, the Navy gave conflicting versions of their practices and the Air Force said they aren’t required to document or report up the results of their reviews.

The head of Defense Pricing and Contracting agreed that $52 million had gone undocumented, but denied that the other $53 million was improperly spent.

“However, we concluded that the expenditure of funds were not necessary or reasonable for the intended and reported purpose (DoD’s COVID-19 response) and, therefore, met the definition of a questioned cost,” according to the report, adding that the official provide a response to the IG addressing the issue directly.

The IG recommended that the Government Purchase Card program not only “re-emphasize” the importance of documenting payment, but also create a process that will at least semiannually review purchases made in the name of a contingency operation, as well as create new oversight rules for the program in general.

As of the report’s release, Defense Pricing and Contracting has agreed to the recommendations, but hasn’t completed them.

This story was originally published on militarytimes.com. You can read it here.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More